New weight loss drugs can cause decline in skeletal muscle mass: Study
New Delhi, Oct 27 (IANS) Amid the growing use of weight loss medications, a new study has raised concerns about declining skeletal muscle health caused by the popular drugs. In a recent commentary published in The Lancet journal, researchers from the US and Canada highlighted the critical importance of skeletal muscle mass in the context
New Delhi: Amid the growing use of weight loss medications, a new study has raised concerns about declining skeletal muscle health caused by the popular drugs.
In a recent commentary published in The Lancet journal, researchers from the US and Canada highlighted the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists.
While the drugs have shown extreme potential in treating obesity — a precursor for many diseases like diabetes, hypertension, and cancer — they can also lead to substantial muscle loss as part of the weight loss process, argued researchers from Pennington Biomedical Research Center in the US, Universities of Alberta and McMaster in Canada.
They noted that muscle loss — measured by decreases in fat-free mass — can account for 25 to 39 per cent of total weight lost through the 36 to 72 weeks. The role of skeletal muscle is not only for maintaining physical strength and function but it is also crucial for metabolic health and regulation of the body’s immune system.
The team found that GLP-1 receptor agonists lead to significantly larger muscle decline than with a non-pharmacological caloric restriction diet or normal ageing. This, the researchers said, “could lead to unintended negative health consequences”.
People with poor muscle mass have decreased immunity, and are at increased risk of infections, poor glucose regulation, and other health risks.
Further, the researchers noted that muscle loss caused by weight reduction can also worsen sarcopenic obesity — prevalent among individuals with obesity, and contributes to cardiovascular disease and higher mortality rates.
Dr. Steven Heymsfield, professor of metabolism and body composition at Pennington, called on people going for weight loss drugs to be “mindful of the side effects”. He added that, while on the medications people are “eating less and not getting the appropriate amount of dietary vitamins and minerals”.
An adequate amount of protein along with an optimum amount of exercise should be explored along with the medications, suggested the researchers.
–IANS
State BJP Govt Has Failed Miserably in Handling Cyclone Dana: BJD
Next ArticleOdisha CM conducts aerial survey in cyclone-affected areas
Related Articles
Sci & TechApple eyes $4 trillion market valuation amid robust iPhone 17 series sales
New Delhi: Riding on the stellar performance of the new iPhone 17 series, Apple is heading towards the $4 trillion market valuation, thus becoming the second-most valuable company after chip major Nvidia. Apple shares surged to an all-time high at $262.9 on Monday (US time). This took the company to a market valuation of nearly
Sci & TechData is the new oil, data centres new refineries: Ashwini Vaishnaw
New Delhi: Underlining India’s ambitious digital transformation agenda, Union Minister for Electronics and Information Technology, Ashwini Vaishnaw, on Saturday described data as “the new oil” and data centres as “the new refineries.” Speaking at the ‘NDTV Word Summit’ here, the minister emphasised the government’s vision of Aatmanirbharta, saying India aims to become self-sufficient in critical
Sci & TechUttarakhand to host precursor for India-AI Impact Summit on October 17
New Delhi: The Uttarakhand state government will hold the Uttarakhand AI Impact Summit 2025 on October 17 in Dehradun, in collaboration with the India AI Mission and the Ministry of Electronics and IT, the government informed on Thursday. The event is a pre-summit to the India-AI Impact Summit 2026, scheduled to take place on February
